Tern Plc comments on significant rise in the share price of Wyld Networks AB

Tern - Wyld Networks

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things (“IoT”) technology businesses, has noted the recent rise in the Company’s share price. The Board also notes today’s significant rise in the share price of Wyld Networks AB. Wyld Networks has published a press release today in relation to the signing of an agreement with SpaceX to discuss potential areas of collaboration.

Wyld Networks is a portfolio company of Tern’s in which Tern currently owns approximately 27%.

Extracted from a translation of the Wyld Networks press release:

“Space X offers satellite connectivity for broadband through Starlink and connectivity for IoT through Swarm. Wyld and SpaceX will explore potential areas of collaboration to collect data from IoT sensors in remote locations.

Satellite connectivity can help bridge the digital divide and increase the reach and resilience of connections for IoT devices. This is particularly the case for the 85% of the Earth’s surface that has no cellular coverage.

Both SpaceX and Wyld Networks operate on low-bandwidth satellite connectivity using satellites orbiting in low orbit. These satellites cover every point on Earth, enabling IoT devices to operate and deliver data at an affordable price, anywhere on Earth.

SpaceX and Wyld will initially explore the potential of offering remote connectivity in North, Central and South America.

Wyld Networks’ IoT engineering team is a leader in delivering satellite IoT connectivity solutions. Their innovative technology leads to exceptional performance with satellites orbiting the Earth in low Earth orbit.

“We are excited to explore possible areas with SpaceX where our technology can enable additional connectivity and access to data from sensors and devices in remote locations,” said Alastair Williamson, CEO Wyld Networks. “With Wyld Connect available to deliver data from IoT devices anywhere on Earth, this is a great opportunity to partner with the world’s most important satellite companies.””

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Pharma teams gain early insight into message effectiveness

Talking Medicines gives pharma teams early insight into which messages resonate with healthcare professionals.

Talking Medicines joins 2026 UK AI Index

Talking Medicines joins the UK AI Index 2026, confirming its growing role in data-driven healthcare strategy.

AI in Healthcare 2025

In 2025, AI began reshaping healthcare delivery and marketing with practical applications, signalling a maturing investment landscape.

Talking Medicines targets messaging risk in pharma brand strategy

Talking Medicines reduces messaging risk for pharma brands by measuring real-time HCP response.

Agentless security for untouchable IoT devices

Agentless IoT security provides identity‑driven protection for devices that cannot be directly managed, turning blind spots into governed assets.

Virtual reality surgical training wins industry attention with scalable model

A new VR training solution backed by Orbis and Fundamental XR is gaining global traction by tackling real-world gaps in surgical education.

Search

Search